- $2.73bn
- $4.90bn
- $2.94bn
- 75
- 67
- 100
- 94
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,972 | 2,127 | 2,713 | 3,005 | 2,935 |
Cost of Revenue | |||||
Gross Profit | 2,148 | 1,287 | 1,621 | 2,105 | 2,078 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,460 | 2,018 | 2,438 | 2,824 | 2,831 |
Operating Profit | 512 | 109 | 276 | 181 | 104 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 446 | -7.33 | 151 | 92.6 | 40.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 340 | -8.52 | 112 | 73 | 34.3 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 340 | -8.52 | 112 | 73 | 34.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 340 | -8.52 | 112 | 73 | 34.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.94 | -4.64 | -2.12 | 1.44 | 0.814 |
Dividends per Share |